Post Marketing Information DHCPL 18/03/2024 Zyrtec-D - Risks of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated with the use of pseudoephedrine
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Syrup, Pseudoephedrine HCl 30 mg/5 mL + Triprolidine HCl 1.25 mg/5 mL National Cancer Centre Tablet, Pseudoephedrine HCl 60 mg + Triprolidine HCl 2.5 mg National Healthcare Group Polyclinics Tan Tock Seng Hospital
ORAL Select a brand starting with the letter: A B D F P ACTIHIST SYRUP [SIN10474P] ACTIMIN TABLET [SIN03927P] BEACTAFED SYRUP [SIN03143P] DECONDINE SYRUP [SIN03181P] DECONDINE TABLET [SIN09453P] FEDAC SYRUP [SIN03193P] FEDAC TABLET [SIN03116P] PEACEF SYRUP 30 MG/5 ML [SIN11124P]